FUL Stock Analysis: H Fuller | NYSE

Specialty Chemicals | NYSE, USA | Market Cap: 3.123m USD | 12M Return: -10.8% | Charts, Fundamentals & Technical Analysis

Adhesives, Sealants, Coatings, Polymers
Total Rating 36
Safety 73
Buy Signal -0.57
Specialty Chemicals
Industry Rotation: -1.8
Market Cap: 3.12B
Avg Turnover: 55.6M
Risk 3d forecast
Volatility42.1%
VaR 5th Pctl7.09%
VaR vs Median2.32%
Reward TTM
Sharpe Ratio-0.30
Rel. Str. IBD14.8
Rel. Str. Peer Group6.8
Character TTM
Beta0.842
Beta Downside1.112
Hurst Exponent0.571
Drawdowns 3y
Max DD43.45%
CAGR/Max DD-0.16
CAGR/Mean DD-0.38
EPS (Earnings per Share) EPS (Earnings per Share) of FUL over the last years for every Quarter: "2021-05": 0.94, "2021-08": 0.79, "2021-11": 1.09, "2022-02": 0.8, "2022-05": 1.11, "2022-08": 1.06, "2022-11": 1.04, "2023-02": 0.55, "2023-05": 0.93, "2023-08": 1.06, "2023-11": 1.32, "2024-02": 0.67, "2024-05": 1.12, "2024-08": 1.13, "2024-11": 0.92, "2025-02": 0.54, "2025-05": 1.18, "2025-08": 1.26, "2025-11": 1.28, "2026-02": 0.57, "2026-05": 1.41,
EPS CAGR: 4.68%
EPS Trend: 58.8%
Last SUE: 0.29
Qual. Beats: 0
Revenue Revenue of FUL over the last years for every Quarter: 2021-05: 827.873, 2021-08: 826.83, 2021-11: 897.424, 2022-02: 856.482, 2022-05: 993.258, 2022-08: 941.23, 2022-11: 958.213, 2023-02: 809.183, 2023-05: 898.239, 2023-08: 900.634, 2023-11: 902.879, 2024-02: 810.419, 2024-05: 917.107, 2024-08: 917.927, 2024-11: 923.284, 2025-02: 788.663, 2025-05: 898.095, 2025-08: 892.043, 2025-11: 894.788, 2026-02: 770.844, 2026-05: 950.271,
Rev. CAGR: -0.65%
Rev. Trend: -59.8%
Last SUE: 0.08
Qual. Beats: 0

Warnings

Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 10.5 years of data

Jan -2.9% 43
Feb -0.8% 0
Mar -1.4% 2
Apr -0.1% 5
May +1.9% 6
Jun +1.8% 0
Jul +2.6% 10
Aug -0.1% 8
Sep -6.9% 36
Oct -0.8% 6
Nov +5.3% 40
Dec -1.4% 6

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: FUL H Fuller

H.B. Fuller Company (NYSE: FUL) is a U.S.-based specialty chemicals manufacturer that formulates and sells adhesives, sealants, coatings, polymers, tapes, and related products. Founded in 1887 and headquartered in Saint Paul, Minnesota, the company operates through three reportable segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives, serving diverse end markets including packaging, hygiene, transportation, electronics, construction, and aerospace. Fuller distributes its products globally across North America, Latin America, Europe, India, the Middle East, Africa, and Asia Pacific through direct sales, distributors, and retailers.

As a specialty chemicals producer, Fuller competes in a sector characterized by formulations tailored to specific customer applications rather than commodity-style volume sales, with product performance and technical service typically serving as key differentiators. Its broad product portfolio spanning consumer-facing applications (hygiene, packaging) and industrial end uses (electronics, aerospace, clean energy) reflects the diversified revenue model common among mid-cap specialty chemical issuers.

Headlines to Watch Out For
  • Raw material costs pressure specialty adhesive margins
  • Hygiene and packaging volumes track global consumer goods demand
  • Building Adhesives revenue tied to North American construction activity
Piotroski VR-10 (Strict) 4.0
Net Income: 185.7m TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.35 > 1.0
NWC/Revenue: 17.68% < 20% (prev 17.08%; Δ 0.61% < -1%)
CFO/TA 0.06 > 3% & CFO 322.9m > Net Income 185.7m
Net Debt (2.02b) to EBITDA (593.1m): 3.40 < 3
Current Ratio: 1.80 > 1.5 & < 3
Outstanding Shares: last quarter (55.1m) vs 12m ago 0.21% < -2%
Gross Margin: 32.53% > 18% (prev 30.19%; Δ 2.34% > 0.5%)
Asset Turnover: 67.07% > 50% (prev 68.74%; Δ -1.67% > 0%)
Interest Coverage Ratio: 3.10 > 6 (EBIT TTM 409.6m / Interest Expense TTM 132.1m)
Altman Z'' 3.24
A: 0.12 (Total Current Assets 1.40b - Total Current Liabilities 779.1m) / Total Assets 5.33b
B: 0.39 (Retained Earnings 2.09b / Total Assets 5.33b)
C: 0.08 (EBIT TTM 409.6m / Avg Total Assets 5.23b)
D: 0.64 (Book Value of Equity 2.08b / Total Liabilities 3.25b)
Altman-Z'' = 3.24 = A
Beneish M -3.06
DSRI: 1.07 (Receivables 622.7m/584.0m, Revenue 3.51b/3.53b)
GMI: 0.93 (GM 30.19% / 32.53%)
AQI: 0.96 (AQ_t 0.56 / AQ_t-1 0.58)
SGI: 0.99 (Revenue 3.51b / 3.53b)
TATA: -0.03 (NI 185.7m - CFO 322.9m) / TA 5.33b)
Beneish M = -3.06 (Cap -4..+1) = AA
What is the price of FUL shares?

As of July 09, 2026, the stock is trading at USD 55.19 with a total of 1,285,865 shares traded. Over the past week, the price has changed by -5.32%, over one month by -8.06%, over three months by -11.73% and over the past year by -10.79%.

Current recommended Stop Loss: 52.10 (which is 5.6% or 1.3 ATR below the current price).

Is FUL a buy, sell or hold?

H Fuller has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold FUL.

  • StrongBuy: 2
  • Buy: 0
  • Hold: 3
  • Sell: 1
  • StrongSell: 0

What are the forecasts/targets for the FUL price?
Analysts Target Price 73.3 32.8%
H Fuller (FUL) - Fundamental Data Overview as of 04 July 2026
Market Cap USD = 3.12b (3.12b USD * 1.0 USD.USD)
P/E Trailing = 17.2285
P/E Forward = 11.7647
P/S = 0.8902
P/B = 1.4795
P/EG = 2.2026
Revenue TTM = 3.51b USD
EBIT TTM = 409.6m USD
EBITDA TTM = 593.1m USD
Long Term Debt = 2.07b USD (from longTermDebt, last quarter)
 Short Term Debt = unknown (none)
 Debt = 2.13b USD (corrected: LT Debt 2.07b + ST Debt none) + Leases 59.1m
Net Debt = 2.02b USD (calculated: Debt 2.13b - CCE 114.1m)
Enterprise Value = 5.14b USD (3.12b + Debt 2.13b - CCE 114.1m)
Interest Coverage Ratio = 3.10 (Ebit TTM 409.6m / Interest Expense TTM 132.1m)
EV/FCF = 36.51x (Enterprise Value 5.14b / FCF TTM 140.8m)
FCF Yield = 2.74% (FCF TTM 140.8m / Enterprise Value 5.14b)
FCF Margin = 4.01% (FCF TTM 140.8m / Revenue TTM 3.51b)
Net Margin = 5.29% (Net Income TTM 185.7m / Revenue TTM 3.51b)
Gross Margin = 32.53% ((Revenue TTM 3.51b - Cost of Revenue TTM 2.37b) / Revenue TTM)
Gross Margin QoQ = 33.91% (prev 31.26%)
Tobins Q-Ratio = 0.96 (Enterprise Value 5.14b / Total Assets 5.33b)
Interest Expense / Debt = 6.20% (Interest Expense 132.1m / Debt 2.13b)
Taxrate = 24.86% (61.5m / 247.3m)
NOPAT = 307.8m (EBIT 409.6m * (1 - 24.86%))
Current Ratio = 1.80 (Total Current Assets 1.40b / Total Current Liabilities 779.1m)
Debt / Equity = 1.02 (Debt 2.13b / totalStockholderEquity, last quarter 2.08b)
Debt / EBITDA = 3.40 (Net Debt 2.02b / EBITDA 593.1m)
Debt / FCF = 14.33 (Net Debt 2.02b / FCF TTM 140.8m)
Total Stockholder Equity = 2.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.55% (Net Income 185.7m / Total Assets 5.33b)
RoE = 9.16% (Net Income TTM 185.7m / Total Stockholder Equity 2.03b)
RoCE = 9.99% (EBIT 409.6m / Capital Employed (Equity 2.03b + L.T.Debt 2.07b))
RoIC = 6.94% (NOPAT 307.8m / Invested Capital 4.44b)
WACC = 7.20% (E(3.12b)/V(5.25b) * Re(8.94%) + D(2.13b)/V(5.25b) * Rd(6.20%) * (1-Tc(0.25)))
Discount Rate = 8.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -46.67 | Cagr: -1.19%
[DCF] Terminal Value 77.97% ; FCFF base≈131.5m ; Y1≈150.8m ; Y5≈221.9m
[DCF] Fair Price = 24.58 (EV 3.34b - Net Debt 2.02b = Equity 1.32b / Shares 53.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 58.82 | EPS CAGR: 4.68% | SUE: 0.29 | # QB: 0
Revenue Correlation: -59.79 | Revenue CAGR: -0.65% | SUE: 0.08 | # QB: 0
EPS current Quarter (2026-08-31): EPS=1.47 | Chg30d=+4.75% | Revisions=-25% | Analysts=7
EPS current Year (2026-11-30): EPS=4.87 | Chg30d=+3.24% | Revisions=+25% | GrowthEPS=+14.8% | GrowthRev=+4.7%
EPS next Year (2027-11-30): EPS=5.32 | Chg30d=+3.56% | Revisions=+25% | GrowthEPS=+9.3% | GrowthRev=+7.8%
[Analyst] Revisions Ratio: +17% (up=2, down=1)